DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sotrovimab
Sotrovimab
Emergency Use Authorization (EUA) for Sotrovimab 500 Mg Center for Drug Evaluation and Research (CDER) Review
Updates on COVID-19 Monoclonal Antibody Treatment In
Policy Brief 002 Update 07.2021
FCDPH- Health Update- Monoclonal Antibody Treatments for COVID-19
COVID-19 (Updated 06/29/2021)
Emerging Treatment Update: Suspected COVID-19 P.1
Assessment Report
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology's
Monoclonal Antibody (MAB) Therapy Infusion Resources in Alameda
Administering Monoclonal Antibody Treatments for COVID-19 in Your Facility
TAG Mail – 26 August 2021 COVID-19 RESOURCES & ARTICLES of INTEREST Please Click This Link for the Cumulative Listing of COVID-19 Resources in Past TAG Mails
Health Update August 24, 2021
'Super-Antibodies' Could Curb COVID-19 and Help Avert Future
Medizinische Biotechnologie in Deutschland 2021
Emtree Terms Added and Changed (January 2021)
Emergency Use Authorization (EUA)
Interim Clinical Guidance for Adults with Suspected Or Confirmed Covid-19 in Belgium
COVID-19: Unmasking Emerging SARS-Cov-2 Variants, Vaccines and Therapeutic Strategies
Top View
Monoclonal Antibody COVID-19 Treatment for Non-Hospitalized
COVID-19 Vaccine, Mrna (Moderna) (Systemic)
Fact Sheet for Healthcare Providers Emergency Use Authorization (Eua) of Sotrovimab
COVID-19 Vaccine and Monoclonal Antibody Infusions Policy
Pause on Monoclonal Antibody Treatment Bamlanivimab/Etesevimab
Alphabetical Listing by Therapeutic Category Dod UNIFORM
Dphhs Han Update 2021-25
HERC Presentation
SARS-Cov-2 Variants: a Synopsis of in Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
Monoclonal Antibodies
COVID-19 Vaccine, Mrna (Moderna)
Monoclonal Antibodies for COVID-19
COVID-19 Monoclonal Antibodies Side- By-Side Comparison
Emerging SARS-Cov-2 Variants of Concern Selected CDC/World Health Organization Designees with Published Clinical Data Version 7/30/21
Use of Monoclonal Antibody Products to Treat COVID-19 in Washington State
Planning and Preparedness
Alphabetical Listing by Name Dod UNIFORM OUTPATIENT
Press Release
International Nonproprietary Names for Pharmaceutical Substances (INN)
PDF of Antibody News
Sotrovimab Infusion Guide
Policy Brief 002 Update 05.2021.Pdf
Frequently Asked Questions on the Emergency Use Authorization of Sotrovimab
FCDPH- Health Update- Monoclonal Antibody Treatments for COVID-19
Toolkit for LTC Medical Directors
Alert Administration of Monoclonal Antibodies for COVID-19 Updated Guidance
Assessment of Evidence for COVID-19-Related Treatments
Sotrovimab Detailed Guide
Pfizer- Biontech COVID-19 Vaccine Induces SARS-Cov-2 Neutralizing Titers and S1-Binding Igg Parenteral Levels
COVID-19 Vaccine, Mrna (Pfizer-Biontech) Interchangeable with Each Other
GSK Sotrovimab Fact Sheet for Patients, Parents, and Caregivers 05262021
JUNE 2021 Part A.Pdf
Stakeholder Update: COVID-19 MCS August 5, 2021
Sotrovimab Product Monograph Page 1 of 24 RECENT MAJOR LABEL CHANGES None
COVID-19: Failure of the Discovery Clinical Trial, and Now–New Hopes?
September 2021 Snap Shot COVID-19 Data Information for These Slides Is from Public Sources
Monoclonal Antibody Treatment for COVID-19
Les Anticorps Monoclonaux Anti-Sars-Cov-2 Et Le Rôle Essentiel
COVID-19 Billing and Coding Guidance Mainecare
The Science Behind Monoclonal Antibodies for COVID-19: Frequently Asked Questions